is yet more proof that this is an area on the cusp of the pharmaceutical R&D mainstream. That was one of the key messages from SynBioBeta’s Synthetic Biology Biopharma Conference last month ...

Currently accounting for around 20 per cent of the overall generic drug sales globally, the Indian pharma industry ... to step up their investments in R&D and innovation to sustain growth momentum.

As technological advancements like AI, machine learning and precision medicine revolutionise drug discovery, manufacturing and patient care, Indian pharmaceutical ... in R&D and innovation to ...

As technological advancements like AI, machine learning and precision medicine revolutionise drug discovery, manufacturing and patient care, Indian pharmaceutical industry is set for a 'profound ...

Getting a clear view of which companies are really 'walking the talk' in pharma and delivering meaningful innovation can often be less than straightforward. Hype, a relentless focus on shareholder ...

In this Pharmaceutical Executive video interview, Angela Tenuta, President, Full Service Agencies, at EVERSANA INTOUCH, explores the findings of their study What Matters Most: The Trends That Will ...

However, fast-selling GLP-1 medications are also bringing more R&D energy back to the small molecule arena with wider patient pools. Amid this backdrop, here are the forces shaping pharma’s ...

With the power of generative AI, we hope to further streamline the innovation process, in the pharmaceutical industry and beyond." In 2016, Insilico first described the concept of using ...

The industry body has made a strong pitch for incentives to promote R&D and innovation in capital-intensive electronics hardware sector during a recent interaction with Finance Minister Nirmala ...

New Delhi, Dec 26 (PTI) As technological advancements like AI, machine learning and precision medicine revolutionise drug discovery, manufacturing and patient care, Indian pharmaceutical industry is ...